A Review on the Relationship between SGLT2 Inhibitors and Cancer.

Int J Endocrinol · 2014 · PMC4164126 · PMID 25254045

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, this was not similarly observed in patients treated with canagliflozin, which actually showed a trend of decreased risk ( Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.